Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
by Dreyling, Martin (Author)
, Jurczak, Wojciech (Author)
, Jerkeman, Mats (Author)
, Silva, Rodrigo Santucci (Author)
, Rusconi, Chiara (Author)
, Trneny, Marek (Author)
, Offner, Fritz (Author)
, Caballero, Dolores (Author)
, Joao, Cristina (Author)
, Witzens-Harig, Mathias (Author)
, Hess, Georg (Author)
, Bence-Bruckler, Isabelle (Author)
, Cho, Seok-Goo (Author)
, Bothos, John (Author)
, Goldberg, Jenna D (Author)
, Enny, Christopher (Author)
, Traina, Shana (Author)
, Balasubramanian, Sriram (Author)
, Bandyopadhyay, Nibedita (Author)
, Sun, Steven (Author)
, Vermeulen, Jessica (Author)
, Rizo, Aleksandra (Author)
, Rule, Simon (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource